Lymphocytic choriomeningitis virus: ways to establish and maintain non-cytolytic persistent infection

Acta Virologica
|March 17, 2016
PubMed

Insights

Lymphocytic choriomeningitis virus (LCMV) uses specific strategies to establish and maintain persistent infections by manipulating host cells. Understanding these mechanisms is crucial for developing therapies against this neglected human pathogen.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Lymphocytic choriomeningitis virus (LCMV) is a prototype Arenaviridae virus.
  • LCMV serves as a model for viral infections and is a human pathogen.
  • LCMV can establish persistent infections and evade immune responses.

Purpose of the Study:

  • To describe LCMV strategies for establishing long-term infection in vitro and in vivo.
  • To discuss viral component manipulation of host cell machinery.
  • To highlight the importance of understanding these strategies for therapeutic development.

Main Methods:

  • Review of existing literature on LCMV infection strategies.
  • Analysis of viral components (RNA, nucleoprotein, glycoprotein, Z protein) and their functions.
  • Discussion of in vitro and in vivo models of LCMV persistence.

Main Results:

  • LCMV employs specific molecular strategies to ensure viral survival and spread.
  • Viral components like RNA, nucleoprotein, glycoprotein, and Z protein are key to manipulating host cells.
  • These manipulations allow virus persistence without disrupting essential cellular processes.

Conclusions:

  • Understanding LCMV's persistence strategies is vital for controlling viral spread.
  • Targeting these viral mechanisms could lead to new therapeutic approaches.
  • Further research is needed to fully elucidate and exploit these viral evasion tactics.